Ninfa Saunders - 01 Jan 2023 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
Director
Signature
/s/ Michael Gibbs, Attorney-in-fact
Issuer symbol
TTOO
Transactions as of
01 Jan 2023
Transactions value $
$0
Form type
4
Filing time
16 Aug 2023, 17:00:49 UTC
Previous filing
13 Oct 2022
Next filing
11 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Options Exercise +1.55K +51.36% 4.57K 01 Jan 2023 Direct F1
transaction TTOO Common Stock Options Exercise +454 +9.94% 5.02K 06 Aug 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTOO Restricted Stock Units Options Exercise $0 -1.55K -100% $0.00* 0 01 Jan 2023 Common Stock 1.55K Direct F1, F2
transaction TTOO Restricted Stock Units Options Exercise $0 -454 -100% $0.00* 0 06 Aug 2023 Common Stock 454 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 On January 1, 2022 the reporting person was granted 1,550 RSU's that vested in one installment on January 1, 2023.
F3 On August 6, 2020 the reporting person was granted 1,363 RSU's that vest in three equal annual installments beginning on August 6, 2021.